Morphine withdrawal typically begins within 8 to 24 hours after the last dose and follows a roughly predictable arc: early flu-like discomfort gives way to a peak of intense physical and psychological symptoms around days two and three, then gradually eases over the course of a week. The experience is rarely life-threatening for otherwise healthy adults, but it is genuinely miserable, and the severity depends on how long you used morphine, how much you were taking, and your individual biology. Understanding the progression in concrete terms can help you or someone you care about prepare for what’s coming and make better decisions about medical support.
Why Withdrawal Happens in the First Place
When you take morphine regularly, your brain adapts. Opioid receptors become less responsive, and the body compensates by ramping up certain signaling systems, particularly noradrenaline pathways originating in a brain region called the locus coeruleus. As long as morphine is present, those compensatory changes are masked. Remove the morphine, and you get a rebound surge of noradrenaline that produces many of the hallmark symptoms: racing heart, sweating, anxiety, gut cramps, and agitation.1PubMed Central. A Comprehensive Update of Lofexidine for the Management of Opioid Withdrawal Symptoms Research on the molecular details of this process, particularly the role of a signaling molecule called cAMP in noradrenergic neurons, shows that the hyperexcitability of these brain cells during withdrawal depends on specific transcription factors, though their exact contribution to each behavioral symptom is still being worked out.2PubMed. Effects of the cell type-specific ablation of the cAMP-responsive transcription factor in noradrenergic neurons on locus coeruleus firing and withdrawal behavior after chronic exposure to morphine
The First 24 Hours
Withdrawal from morphine usually announces itself within 8 to 12 hours of the last dose, though the exact timing depends on the formulation. Extended-release morphine hangs around longer in the body, so onset may be slightly delayed compared to immediate-release versions. The earliest signs tend to be subtle and easy to mistake for a mild cold or general restlessness:
- Yawning and tearing up: excessive, uncontrollable yawning along with watery eyes and a runny nose.
- Sweating: often noticeable even in a cool room.
- Muscle aches: a generalized soreness, commonly described as feeling like you’re coming down with the flu.
- Anxiety and agitation: a mounting unease that goes beyond ordinary nervousness.
- Insomnia: difficulty falling or staying asleep, despite feeling exhausted.
These early symptoms are uncomfortable but manageable for most people. The danger at this stage is less about medical risk and more about the powerful urge to take more morphine to make it stop. Research consistently shows that craving and anxiety are tightly linked during opioid withdrawal, suggesting they share overlapping brain pathways. In one study of people going through opioid withdrawal, craving and anxiety showed the strongest positive correlation of all withdrawal symptoms measured.3Journal of Substance Abuse. The relationship between craving, anxiety, and other symptoms in opioid withdrawal
Days Two and Three: The Peak
Somewhere around 36 to 72 hours after the last dose, withdrawal intensity reaches its highest point. Everything from the first day gets worse, and new symptoms layer on top:
- Gastrointestinal distress: nausea, vomiting, diarrhea, and stomach cramps. Dehydration becomes a real concern here.
- Goosebumps and chills: the classic “cold turkey” appearance, where the skin puckers and you alternate between feeling freezing and feverish.
- Dilated pupils: often noticeable to others before you’re aware of it yourself.
- Elevated heart rate and blood pressure: part of the noradrenaline rebound. Studies on precipitated withdrawal in opioid-dependent people confirmed that signs like increased heart rate, lacrimation (tearing), and rhinorrhea (runny nose) persist even when blood pressure is brought down with certain medications, highlighting that autonomic symptoms involve more than just cardiovascular changes.4PubMed. Evaluation of the effects of lofexidine and clonidine on naloxone-precipitated withdrawal in opioid-dependent humans
- Intense craving: arguably the most dangerous symptom, because it drives relapse even when someone is fully committed to quitting.
This peak phase is when most people describe withdrawal as feeling unbearable. The combination of physical agony and psychological desperation creates an experience that, while not typically fatal, is profoundly distressing. People with underlying heart conditions, severe dehydration from vomiting and diarrhea, or other medical vulnerabilities do face genuine health risks during this window, which is why medically supervised withdrawal is strongly recommended.
Days Four Through Seven and Beyond
After the peak, physical symptoms begin to recede. The gut calms down, the sweating lets up, and the worst of the aches start to fade. By about day five to seven, most of the acute physical signs have resolved or at least become tolerable. Sleep remains disrupted for many people well past this point, and low-level irritability, fatigue, and mood swings can linger for weeks.
This improvement is real but deceptive. The fading of dramatic physical symptoms gives many people the impression that they are “through it,” when the psychological dimension of withdrawal is only getting started. Craving, low motivation, difficulty concentrating, and emotional flatness can persist for months. This protracted withdrawal phase is less well-defined than the acute timeline, but it is a major driver of relapse. People who expect withdrawal to be a one-week ordeal are often blindsided by mood and sleep problems that stretch on much longer.
Sex Differences in the Withdrawal Timeline
There is growing evidence that men and women experience morphine withdrawal differently. Animal research using morphine-dependent rats found that males showed more severe symptoms during the early phases of withdrawal, while females had lower overall severity initially but experienced symptoms that persisted longer. By the later stages, females actually demonstrated higher withdrawal-symptom severity than males.5PubMed Central. Sex differences in the expression of morphine withdrawal symptoms and associated activity in the tail of the ventral tegmental area While animal studies don’t map perfectly onto humans, this pattern aligns with anecdotal clinical observations that women sometimes report a more drawn-out withdrawal course. Hormonal differences, body composition, and variations in opioid receptor density all likely contribute, though this remains an area where the research is thinner than it should be.
How Clinicians Measure Withdrawal Severity
If you go through withdrawal in a clinical setting, staff will likely use a standardized scoring tool called the Clinical Opiate Withdrawal Scale, or COWS. It assigns points across 11 different measures, covering things like resting pulse, sweating, restlessness, pupil size, bone or joint aches, runny nose, GI symptoms, tremor, yawning, anxiety, and gooseflesh skin. The total score places you into severity categories that guide treatment decisions.6JACEP Open. Interobserver agreement between emergency clinicians and nurses for Clinical Opiate Withdrawal Scale A COWS score above 13, for example, signals moderate withdrawal and is a threshold sometimes used to determine when it’s safe to begin certain medications like buprenorphine.7PubMed. Buprenorphine precipitated opioid withdrawal: Prevention and management in the ED setting
The COWS matters for practical reasons beyond just tracking how miserable you are. Some medications for opioid use disorder must be timed carefully to avoid making withdrawal worse, and the score helps providers judge when the moment is right.
Medical Management Options
Going through morphine withdrawal without medical support is possible but unnecessarily painful, and it increases the risk of relapse and dangerous complications. Several medication strategies exist, and they fall into two broad camps: opioid-based treatments and non-opioid symptom management.
Opioid-Based Treatments
Methadone and buprenorphine are the two main opioid-based medications used to manage withdrawal and longer-term opioid use disorder. Both can diminish withdrawal symptoms and cravings as well as block opioid effects in the event of relapse.8PubMed. Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management Methadone is a long-acting opioid agonist that occupies the same receptors as morphine, easing withdrawal without producing the same high at proper doses. Buprenorphine is a partial agonist, meaning it activates opioid receptors but to a lesser degree. It has a ceiling effect that makes overdose less likely.
The catch with buprenorphine is timing. Standard protocols require you to stop taking morphine and wait until you are in moderate withdrawal before the first dose, because buprenorphine can actually displace other opioids from receptors and precipitate sudden, severe withdrawal if given too early.9PubMed Central. The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder This precipitated withdrawal is distinct from normal withdrawal: it comes on fast, within minutes to hours of the dose, and can be more intense than what would have developed naturally. Emergency departments have documented cases where patients received buprenorphine too soon and experienced an acute worsening of symptoms.10PubMed Central. Precipitated opioid withdrawal after buprenorphine administration in patients presenting to the emergency department: A case series Newer approaches, sometimes called microinduction, use very small initial doses to avoid this problem, but the technique requires careful medical supervision.
Non-Opioid Medications
Lofexidine, an alpha-2 adrenergic agonist, is FDA-approved specifically for managing opioid withdrawal symptoms. It works by dampening the noradrenaline surge that drives so much of the withdrawal syndrome.11PubMed Central. The Role of Lofexidine in Management of Opioid Withdrawal Clonidine, a related drug originally developed for high blood pressure, is used off-label for the same purpose. Both reduce cardiovascular symptoms effectively, though research has shown they don’t fully suppress the subjective misery of withdrawal or certain autonomic signs like tearing and runny nose.4PubMed. Evaluation of the effects of lofexidine and clonidine on naloxone-precipitated withdrawal in opioid-dependent humans
Beyond these, clinicians commonly prescribe a menu of targeted medications to tackle individual symptoms: NSAIDs or acetaminophen for muscle and joint pain, ondansetron or similar drugs for nausea, loperamide for diarrhea, diphenhydramine or hydroxyzine for anxiety, and occasionally benzodiazepines used cautiously for severe agitation or insomnia. Increased oral hydration is strongly emphasized, especially when vomiting and diarrhea are draining fluids.12PubMed Central. Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment
The Tolerance Trap After Detox
One of the most dangerous moments in the entire withdrawal process isn’t during withdrawal itself. It comes after. Once you have gone through acute withdrawal, your opioid tolerance drops rapidly. The dose you used to take comfortably can now kill you. A follow-up study of patients who completed inpatient opiate detox found that deaths from overdose clustered among people who had successfully finished treatment, a pattern that only makes sense in terms of lost tolerance making resumed heroin use unpredictable and potentially fatal.13BMJ. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study
This is a critical piece of information that gets undersold in many detox programs. Going through withdrawal is not the same as being safe. If you relapse after even a few days of abstinence, your body no longer has the tolerance buffer that previously kept you alive at higher doses. Naloxone availability and education about this risk should be standard parts of any withdrawal plan.
How Fentanyl Complicates the Picture
Many people who believe they are using morphine or heroin are actually exposed to illicitly manufactured fentanyl, which alters the withdrawal picture in important ways. Fentanyl is extremely potent and highly fat-soluble, meaning it accumulates in body tissue and can continue leaking into the bloodstream for days after the last use. Research has found that people classified as overweight or obese had significantly higher odds of testing positive for fentanyl across the first ten days of monitored withdrawal compared to those at a healthy weight.14PubMed Central. Fentanyl withdrawal: Understanding symptom severity and exploring the role of body mass index on withdrawal symptoms and clearance This slow clearance can delay withdrawal onset, extend the acute phase, and make buprenorphine induction especially tricky, since the drug may still be occupying receptors well past when you’d expect it to be gone.
If you’re going through withdrawal and your opioid source was street drugs, it’s worth assuming fentanyl was involved. The timeline you experience may be longer and less predictable than the classic morphine withdrawal arc described above, and medical providers need to know, because it changes medication timing decisions.
Neonatal Withdrawal
Morphine withdrawal isn’t limited to adults who choose to stop using. Infants born to mothers who used opioids during pregnancy can develop neonatal opioid withdrawal syndrome, sometimes called NAS or NOWS. Because opioid receptors are concentrated in the central nervous system and the gastrointestinal tract, the predominant signs in newborns reflect those systems: tremors, excessive crying, poor feeding, and loose stools. The timing of onset depends on which opioid the mother was taking. Withdrawal from heroin often begins within 24 hours of birth, while withdrawal from methadone usually begins at roughly 24 to 72 hours. In some cases, withdrawal may be delayed until 5 to 7 days after birth, which is typically after hospital discharge for uncomplicated term infants. Subacute signs can last up to 6 months.15Pediatrics. Neonatal Opioid Withdrawal Syndrome
Genetic factors also play a role in how severely a newborn is affected. Small studies have identified variants in opioid receptor and stress response genes that are associated with differences in how much medication the infant needs and how long they stay in the hospital. Epigenetic variation in the mu opioid receptor gene has also been linked to differences in hospitalization outcomes, hinting that identical opioid exposures can produce very different withdrawal courses depending on the infant’s biology.
The Role of Expectations and Anxiety
Something that rarely gets discussed in the context of opioid withdrawal is the degree to which your expectations can shape the experience. Research into placebo and nocebo effects in pain and opioid contexts has found that expecting pain relief releases endogenous opioids and enhances the effects of administered pain medication, while expecting persistent or worsening pain opposes endogenous opioid function and makes tapering harder.16PubMed Central. Optimizing Placebo and Minimizing Nocebo to Reduce Pain, Catastrophizing, and Opioid Use: A Review of the Science and an Evidence-Informed Clinical Toolkit In practical terms, this means that fear and catastrophizing about withdrawal can genuinely make the physical experience worse, not because it’s “all in your head” but because the brain’s pain-modulation systems are responsive to expectation. Clinicians who take time to frame the withdrawal process realistically, acknowledging that it will be difficult but is survivable and time-limited, may actually help reduce the severity their patients experience.
This also connects to the anxiety-craving link mentioned earlier. If anxiety amplifies craving, and catastrophic expectations amplify both anxiety and pain perception, there is a compounding loop that makes unsupported withdrawal harder than it needs to be. Even simple interventions like knowing the timeline, having someone check in on you regularly, and staying hydrated can break parts of that cycle. Withdrawal will never be pleasant, but going in informed and supported makes a measurable difference.